Weight-loss drug delayed
US health regulators have delayed their decision on whether to approve Sanofi-Aventis' highly anticipated weight loss drug, Acomplia.
Read the rest of this entry ... (87 words left)
Weight loss drugs blog provide information and news for different weight loss drugs.
2007/2/25
2007/2/22
Analysts split on Amylin's Byetta
Sanofi aventis' Acomplia -- if it wins FDA approval -- could also impact Byetta. Sanofi is seeking an obesity indication for the drug, but if it gets approved for type 2 diabetes, it could steal some share from Byetta because it too offers the advantage of weight loss.
Read the rest of this entry ... (52 words left)
2007/2/21
Diet Drug Acomplia Seen Unlikely to Get FDA Approval for 'Metabolic Syndrome'
If you were hoping that diet drug rimonabant (Acomplia / Zimulti) would be approved for treatment of "metabolic syndrome" so your insurance company would be more likely to pay for your weight-loss efforts, the current thinking at the U.S. Food and Drug Administration does not appear very encouraging.
Read the rest of this entry ... (139 words left)
2007/2/9
Walking is helpful for weight loss
Hi, According to weight loss experts walking is very helpful for weight loss. As compared to any other exercise and yoga morning walks may also provide more benefits in reducing extra weight for obese patients.
